A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab in Locally Advanced Sinonasal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
- Status
- COMPLETED
- Phase
- PHASE2